BridgeMD
New treatment option for Attention Deficit Disorder With Hyperactivity
Official title tES Modalities for the Treatment of ADHD
ClinicalTrials.gov ID: NCT06974136
What this study is testing
- What it's testing
- This project investigates the efficacy of transcranial electrical stimulation (tES) modalities, specifically transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS), for treating Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 7 to 18
You may be able to join if
- Diagnosis of ADHD by a licensed psychiatrist and a behavioral checklist
- being 7-18 years old
- providing written informed consent signed by parents
You likely can't join if
- comorbidity with other neurodevelopmental disorders
- Comorbidity with other neurological disorders
- previous history of neurosurgery
- Presence of any ferromagnetic metal in the head
- implanted medical devices in the head or neck region
- history of non-controlled epilepsy with seizures in the last year
The study team makes the final eligibility decision.
Where it's taking place
- Tehran, Iran
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 7 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tehran, Iran. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.